Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy-Reference-Cited by-同舟云学术

Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy

Author:

Huang Mingxing¹,Liu Jian¹,Chow Monica²,Zhou Xuan¹,Han Zongping¹,He Zhenjian³,Xue Jinfang¹,Zhu Zhe⁴⁵^ORCID,Li Xinhua⁶,Xia Jinyu¹

Affiliation:

1. Department of Infectious Diseases; The Fifth Affiliated Hospital of Sun Yat-Sen University (SYSU); Zhuhai Guangdong China

2. PGY IV; Department of General Surgery Rutgers; Robert Wood Johnson Medical School; Piscataway NJ USA

3. School of Public Health; Sun Yat-sen University; Guangzhou China

4. Department of Medicine; Division of Regenerative Medicine; University of California; San Diego; School of Medicine; La Jolla CA USA

5. Department of Stem Cell Biology and Regenerative Medicine; Cleveland Clinic; Lerner Research Institute; Cleveland OH USA

6. Department of Infectious Diseases; The Third Affiliated Hospital; Sun Yat-Sen University; Guangzhou Guangdong China

Funder

Guangdong Science and Technology Plan

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

Reference33 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献